Pathway to Success Senior Panel Discussion

Listen to the inspiring journeys of successful senior women and men in science and technology as they talk about their pathways to success. Highlights will include details on their paths, obstacles they overcame, things that helped them along the way, and tips and strategies that can also work for you. This is a great opportunity for you to network with the movers and shakers in the science and technology community and support the career advancement of women in STEM!

Panelists include:

- Ketki Karanam, Co-founder & Head of Science at The Sync Project; Senior Associate at PureTech Ventures
- Joseph Lehar, Head, Computational Biology, verily (formerly Google Life Sciences)
- Laurence Reid, Chief Executive Officer, Warp Drive Bio, LLC
- Danielle Sheer, Vice President and General Counsel, Carbonite
- Paula Soteropoulos, President & CEO, Akcea Therapeutics


Learn more about the panelists:

Ketki Karanam is a Senior Associate at Puretech Health, a cross-disciplinary healthcare company, where she is involved in new company formation initiatives in digital health. She is a co-founder and Head of Science at The Sync Project, a technology company developing a platform to scientifically measure the effects of music on our health, with the goal of developing personalized music therapeutics for a range of conditions including Parkinson’s disease, pain, anxiety and sleep disorders. In 2016, Ketki was named to MedTech Boston’s top 40 under 40 Healthcare Innovators list. Ketki completed her doctoral work at Harvard University in the Department of Systems Biology, focusing on DNA repair in cancer cells. Her work has been published in leading peer-reviewed journals and has received multiple nominations on Faculty of 1000. She also served as a Fellow with the Harvard Office of Technology Development, where she worked on translating emerging life science technologies into commercial healthcare products. Dr. Karanam holds a B.S. in Microbiology, and a M.S. in Biological Sciences from the Indian Institute of Science, during which time she held the national JNCASR and Rajiv Gandhi Science Talent fellowships. She received her PhD in Systems Biology from Harvard. 

Joseph Lehar heads Verily’s computational biology group. Joseph came to Google from Novartis, where he was a director of bioinformatics for Oncology Translational Medicine, and before that he played a key role at CombinatoRx Inc, a biotech focused on drug combinations. Joseph holds a Ph.D. in physics, and his original career was astrophysics, which he pursued at MIT, Cambridge University, and Harvard.

Dr. Laurence Reid has recently been appointed as the Chief Executive Officer of Warp Drive Bio LLC. Laurence brings to Warp Drive over 25 years of experience within the global biotechnology industry, particularly in business development, general management, and strategic planning. Most recently, he served as Chief Business Officer of Alnylam Pharmaceuticals, where he led business development strategy and efforts, including forming the company’s transformational alliance with Genzyme, a Sanofi company and leading other transactions with Merck, Medicines Company, Monsanto, and GlaxoSmithKline. Prior to Alnylam, Dr. Reid was Chief Business Officer at Ensemble Therapeutics, where he led the implementation of key business strategies for the company's therapeutic and diagnostic portfolios, and executed major alliances with Bristol-Myers Squibb, Pfizer Inc, and Hoffman-La Roche. Previously, Dr. Reid worked as a founder of two start-up companies in the fields of stem cell therapeutics and inflammation. He also spent 10 years at Millennium Pharmaceuticals, Inc., where he had worked in a range of general management and business development positions. Roles included General Manager of Millennium UK with responsibility for Millennium's European operations, Vice President of Business Development for the company's predictive medicine efforts, as well as in pharmaceutical business development and technology acquisition. Before joining Millennium, he was an assistant editor of the journal Cell. Dr. Reid received his Ph.D. from London University and his B.A. from Cambridge University. He is a member of the Board of Directors of The Possible Project, a non-profit organization that teaches at-risk youth the skills of entrepreneurship.

Danielle Sheer is Vice President and General Counsel at Carbonite. As the founding member of Carbonite’s legal team, Danielle Sheer played a critical role in leading the company to a NASDAQ listing in 2011. Danielle oversees our global legal and corporate governance affairs, including worldwide data security and privacy compliance, spearheading our technology patent portfolio for Carbonite’s business continuity solutions and guiding our international expansion efforts. Prior to Carbonite, Danielle practiced corporate and securities law at Willkie Farr & Gallagher LLP, where she specialized in technology-related corporate matters and M&A. Danielle was named to the Boston Business Journal's “40 under 40” list of emerging business leaders, honored by the Massachusetts Bar Association and Massachusetts Lawyers Weekly as an “Emerging Leader,” selected as “Maverick of the Year” Stevie award winner for Women in Business, and named an “Emerging Leader for Advancing Women Leaders” by the Boston Business Journal. Danielle received a J.D. from Georgetown University and B.A. with honors from George Washington University. She serves on the board of directors of The Boston Club and the Girl Scouts of Eastern Massachusetts.

Paula Soteropoulos is a global strategic and operating management executive with over 26 years’ success at building high-performance global teams, leading complex development programs from early stage through approval, and commercializing global products. Paula joined Akcea Therapeutics as President and Chief Executive Officer upon its formation in January 2015. Prior, she was at Moderna Therapeutics as the Cardiometabolic and Rare Disease General Manager and SVP of Strategic Alliances. Prior to Moderna, she spent 21 years at Genzyme where she was instrumental in advancing new products from discovery through clinical development and commercialization with significant roles driving strategy, sales and marketing and business development. Additionally, Paula led manufacturing process development, strategic capacity planning and supply chain development. Prior to Genzyme, Paula was a bioprocess engineering consultant for various biopharmaceutical companies. Paula serves on the Board of Directors of uniQure and on the Advisory Board of the Tufts University Chemical/Biological Engineering Department.  She holds her B.S. and Master’s degrees in Chemical and Biochemical Engineering from Tufts University and earned an executive management certificate from Darden School of Business, University of Virginia.  Paula is a past honoree of Mass High Tech’s Women to Watch. 


Date and Time:

September 22, 2016
6:00 - 8:45 PM

Evening’s Schedule

6:00-6:45  Registration, Networking, Appetizers, Wine
6:45-7:00  Welcome, Acknowledgement of Sponsors, Overview of the Evening
7:00-8:15  Panel Discussion
8:15-8:45  Networking

Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142

Map and Parking Info

We appreciate The Broad Institute donating the use of their event space.  


$55 for Members and Broad employees, $75 for non-members 

We have ticket packages available: 

$700 for 10 tickets and one sponsorship table tent
$1,000 for 15 tickets and two sponsorship table tents
$1,300 for 20 tickets and three sponsorship table tents

Cancellation Policy:
All programs are non-refundable.

To Register


Become a sponsor and contribute to a great cause.  For more information, email [email protected], or call 857-600-2598.